No Items In Cart
There is a trend in drug development, especially for biologics, to evaluate higher injection volumes and viscosities. This presents a unique challenge to companies as they assess primary packaging component technologies.
The cartridge has been used as the primary container for the insulin and dental markets for many years. Because the cartridge is a proven container, many companies are evaluating new drug products such as biologics in cartridges to address requirements for larger volume injections.
Historically, cartridge-based delivery systems would leverage the pen injector, but recently, novel devices have been developed with cartridges as primary containers for wearable injectors and auto-injectors. The challenge is that component technologies need to evolve to meet the needs of these new cartridge-based injector systems.
Introducing NovaPure 3mL Cartridge Components
West is excited to launch an addition to its NovaPure product line — NovaPure 3mL Cartridge components. These new components are specifically designed for 3mL cartridges prevalent in pen injectors and other drug delivery devices. They incorporate West’s premium quality enhancements:
With these enhancements, NovaPure 3mL Cartridge components directly address concerns and needs expressed by our customers, making them an ideal choice for sensitive biologic drugs coming to market.Learn more about NovaPure 3mL Cartridge components here.
NovaPure®, Westar® and FluroTec® are registered trademarks of West Pharmaceutical Services Inc. in the United States and other jurisdictions.